While somatic mutations of EGFR, BRAF, HER2, MET and chromosomal rearrangements of ALK, ROS1, RET are responsible for lung cancer, risk factors for these genomic alterations have not yet been identified. Here, ERBB2 is linked to lung carcinoma.